Sodium Butyrate Prevents Memory Impairment by Re-establishing BDNF and GDNF Expression in Experimental Pneumococcal Meningitis

Molecular Neurobiology

Volumn 52, Issue 1, 2015, Pages 734-740

  Barichello, Tatiana ^a,b,c   Generoso, Jaqueline S ^a   Simões, Lutiana R ^a   Faller, Cristiano Julio ^a   Ceretta, Renan A ^a   Petronilho, Fabricia ^b   Lopes Borges, Jéssica ^a   Valvassori, Samira S ^a   Quevedo, João ^a,b  

^a UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

BDNF; GDNF; Memory; NGF; Pneumococcal meningitis; Sodium butyrate

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BUTYRIC ACID; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; SODIUM CHLORIDE;

ADJUVANT THERAPY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; HIPPOCAMPUS; MALE; MEMORY DISORDER; NONHUMAN; OPEN FIELD TEST; PNEUMOCOCCAL MENINGITIS; PROTEIN EXPRESSION; RAT; STEP-DOWN PASSIVE AVOIDANCE TEST; STREPTOCOCCUS PNEUMONIAE; ANIMAL; AVOIDANCE BEHAVIOR; COMPLICATION; DRUG EFFECTS; HABITUATION; MEMORY DISORDERS; MENINGITIS, PNEUMOCOCCAL; METABOLISM; WISTAR RAT;

ANIMALS; AVOIDANCE LEARNING; BRAIN-DERIVED NEUROTROPHIC FACTOR; BUTYRIC ACID; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MEMORY DISORDERS; MENINGITIS, PNEUMOCOCCAL; NERVE GROWTH FACTOR; RATS, WISTAR;

EID: 84937972383     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8914-3     Document Type: Article

References (32)

1. Hoogman M, van de Beek D, Weisfelt M, de Gans J, Schmand B (2007) Cognitive outcome in adults after bacterial meningitis. J Neurol Neurosurg Psychiatry 78(10):1092–1096
2. Merkelbach S, Sittinger H, Schweizer I, Muller M (2000) Cognitive outcome after bacterial meningitis. Acta Neurol Scand 102(2):118–123
3. Schmidt H, Heimann B, Djukic M, Mazurek C, Fels C, Wallesch CW, Nau R (2006) Neuropsychological sequelae of bacterial and viral meningitis. Brain 129(2):333–345
4. Barichello T, Silva GZ, Generoso JS, Savi GD, Michelon CM, Feier G, Comim CM, Quevedo J (2010) Time-dependent behavioral recovery after pneumococcal meningitis in rats. J Neural Transm 117(7):819–826
5. Barichello T, Generoso JS, Milioli G, Elias SG, Teixeira AL (2013) Pathophysiology of bacterial infection of the central nervous system and its putative role in the pathogenesis of behavioral changes. Rev Bras Psiquiatr 35(1):81–87
6. Barichello T, Belarmino E Jr, Comim CM, Cipriano AL, Generoso JS, Savi GD, Stertz L, Kapczinski F, Quevedo J (2010) Correlation between behavioral deficits and decreased brain-derived neurotrophic [correction of neurotrofic] factor in neonatal meningitis. J Neuroimmunol 223(1–2):73–76
7. Li L, Shui QX, Liang K, Ren H (2007) Brain-derived neurotrophic factor rescues neurons from bacterial meningitis. Pediatr Neurol 36(5):324–329
8. Cunha C, Brambilla R, Thomas KL (2010) A simple role for BDNF in learning and memory? Front Mol Neurosci 3(1)
9. Martinez-Levy GA, Cruz-Fuentes CS (2014) Genetic and epigenetic regulation of the brain-derived neurotrophic factor in the central nervous system. The Yale journal of biology and medicine 87(2):173–186
10. Intlekofer KA, Berchtold NC, Malvaez M, Carlos AJ, McQuown SC, Cunningham MJ, Wood MA, Cotman CW (2013) Exercise and sodium butyrate transform a subthreshold learning event into long-term memory via a brain-derived neurotrophic factor-dependent mechanism. Neuropsychopharmacology 38(10):2027–2034
11. Calfa G, Chapleau CA, Campbell S, Inoue T, Morse SJ, Lubin FD, Pozzo-Miller L (2012) HDAC activity is required for BDNF to increase quantal neurotransmitter release and dendritic spine density in CA1 pyramidal neurons. Hippocampus 22(7):1493–1500
12. Wu X, Chen PS, Dallas S, Wilson B, Block ML, Wang CC, Kinyamu H, Lu N, Gao X, Leng Y, Chuang DM, Zhang W, Lu RB, Hong JS (2008) Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol 11(8):1123–1134
13. Kim HJ, Chuang DM (2014) HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammation. Am J Transl Res 6(3):206–223
14. 14. Yoo DY, Kim DW, Kim MJ, Choi JH, Jung HY, Nam SM, Kim JW, Yoon YS, Choi SY, Hwang IK (2014) Sodium butyrate, a histone deacetylase Inhibitor, ameliorates SIRT2-induced memory impairment, reduction of cell proliferation, and neuroblast differentiation in the dentate gyrus. Neurol Res. Epub ahead of print
15. Barichello T, Generoso JS, Simoes LR, Elias SG, Tashiro MH, Dominguini D, Comim CM, Vilela MC, Teixeira AL, Quevedo J (2013) Inhibition of indoleamine 2,3-dioxygenase prevented cognitive impairment in adult Wistar rats subjected to pneumococcal meningitis. Transl Res 162(6):390–397
16. Barichello T, Simoes LR, Generoso JS, Sangiogo G, Danielski LG, Florentino D, Dominguini D, Comim CM, Petronilho F, Quevedo J (2013) Erythropoietin prevents cognitive impairment and oxidative parameters in Wistar rats subjected to pneumococcal meningitis. Transl Res 163(5):503–513
17. Arent CO, Valvassori SS, Fries GR, Stertz L, Ferreira CL, Lopes-Borges J, Mariot E, Varela RB, Ornell F, Kapczinski F, Andersen ML, Quevedo J (2011) Neuroanatomical profile of antimaniac effects of histone deacetylases inhibitors. Mol Neurobiol 43(3):207–214
18. Barichello T, Goncalves JC, Generoso JS, Milioli GL, Silvestre C, Costa CS, Coelho Jda R, Comim CM, Quevedo J (2013) Attenuation of cognitive impairment by the nonbacteriolytic antibiotic daptomycin in Wistar rats submitted to pneumococcal meningitis. BMC Neurosci 14(42):1471–2202
19. Vianna MR, Alonso M, Viola H, Quevedo J, de Paris F, Furman M, de Stein ML, Medina JH, Izquierdo I (2000) Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat. Learn Mem 7(5):333–340
20. Quevedo J, Vianna M, Zanatta MS, Roesler R, Izquierdo I, Jerusalinsky D, Quillfeldt JA (1997) Involvement of mechanisms dependent on NMDA receptors, nitric oxide and protein kinase A in the hippocampus but not in the caudate nucleus in memory. Behav Pharmacol 8(8):713–717
21. Roesler R, Schroder N, Vianna MR, Quevedo J, Bromberg E, Kapczinski F, Ferreira MB (2003) Differential involvement of hippocampal and amygdalar NMDA receptors in contextual and aversive aspects of inhibitory avoidance memory in rats. Brain Res 975(1–2):207–213
22. Bevilaqua LR, Kerr DS, Medina JH, Izquierdo I, Cammarota M (2003) Inhibition of hippocampal Jun N-terminal kinase enhances short-term memory but blocks long-term memory formation and retrieval of an inhibitory avoidance task. Eur J Neurosci 17(4):897–902
23. Izquierdo I, Barros DM, e Souza MT, de Souza MM, Izquierdo IZ, Medina JH (1998) Mechanisms for memory types differ. Nature 393(6686):635–636
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265–275
25. Frey BN, Andreazza AC, Cereser KM, Martins MR, Valvassori SS, Reus GZ, Quevedo J, Kapczinski F (2006) Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci 79(3):281–286
26. Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK (2013) GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther 138(2):155–175
27. 27. Song X, Lian D, He D, Sun J, Zhu M, Li L (2014) The responsiveness of TrkB to exogenous BDNF in frontal cortex during antibiotic treatment of Streptococcus pneumoniae meningitis. Neurol Sci. Epub ahead of print
28. Duarte EP, Curcio M, Canzoniero LM, Duarte CB (2012) Neuroprotection by GDNF in the ischemic brain. Growth Factors 30(4):242–257
29. Katsuragi S, Ikeda T, Ikenoue T (2011) A strategy to treat neonatal hypoxic encephalopathy using glial cell line-derived neurotrophic factor. No to hattatsu Brain and development 43(4):265–272
30. Kim HJ, Leeds P, Chuang DM (2009) The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain. J Neurochem 110(4):1226–1240
31. Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM (2007) Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 321(3):892–901
32. Reolon GK, Maurmann N, Werenicz A, Garcia VA, Schroder N, Wood MA, Roesler R (2011) Posttraining systemic administration of the histone deacetylase inhibitor sodium butyrate ameliorates aging-related memory decline in rats. Behav Brain Res 221(1):329–332